| Market Cap | ₹130Cr | 
| ROE | 9.32% | 
| P/E Ratio(TTM) | 18.10 | 
| EPS(TTM) | 4.51 | 
| P/B Ratio | 1.68 | 
| Dividend Yield | 1.47% | 
| Industry P/E | 34.63 | 
| Book Value | 48.63 | 
| Debt to Equity | 1.94 | 
| Face Value | 10 | 
| Parent Organisation | Bal Pharma | 
| Managing Director | Shailesh Siroya | 
| NSE Symbol | BALPHARMA | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%)  | 86.40  | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%)  | 39.18  | ||
| Emcure Pharmaceuticals | NA (0.00%)  | 32.65  | ||
| Wockhardt | NA (0.00%)  | -450.62  |